The global animal drug compounding market is estimated to register a CAGR of 7.4% over the forecast period of 2022 to 2031, according to a report by Transparency Market Research.
Increase in the global population of companion, as well as exotic pet animals is driving the market growth. Furthermore, rising demand for personalized and at times customizable medications for these companion animals is creating opportunities for the players operating in the animal drug compounding market. Rising approval for these new and innovative drug compounding practices by animal owners is also boosting demand within the market.
Anti-infective drugs, consisting of anti-bacterial drugs, anti-fungal drugs, antiphrastic drugs, and anti-viral drugs, account for the largest demand in the market. Most commonly used to treat or prevent animals from minor infections, these drugs are also useful in treating serious infectious diseases, such as tuberculosis or pneumonia.